In shift, feds target top execs for health fraud
Federal investigators say they are starting to target individual executives in health care fraud cases previously aimed at impersonal corporations.
It’s raising the stakes for corporate honchos at drug companies, medical device manufacturers, nursing home chains and others who deal with Medicare and Medicaid.